Management of Pregabalin Toxicity with Hemodialysis
For patients with pregabalin toxicity, intermittent hemodialysis should be performed as the first-line extracorporeal treatment to rapidly eliminate the drug and resolve symptoms.
Rationale for Hemodialysis in Pregabalin Toxicity
- Pregabalin can be effectively removed by hemodialysis, with standard hemodialysis procedures resulting in approximately 50% clearance in 4 hours 1
- Pregabalin has three key properties that make it highly amenable to removal by hemodialysis:
- Relatively low molecular weight (159.23 Da)
- Low volume of distribution (0.5 L/kg)
- Not bound to plasma proteins 2
- Documented hemodialysis clearance rates of 88.8 mL/min have been achieved, which correlates with rapid resolution of toxicity symptoms 2
Recommended Hemodialysis Protocol
- Modality selection: Intermittent hemodialysis is strongly recommended as the preferred extracorporeal treatment modality 3
- Timing: Initiate hemodialysis promptly upon diagnosis of significant pregabalin toxicity 1
- Duration: Continue hemodialysis until clinical improvement is observed 3
- Frequency: Daily intermittent hemodialysis sessions may be required until toxicity resolves 3
Optimizing Hemodialysis Parameters
- Use higher blood flow rates and dialyzers with larger surface area to enhance clearance 3
- Optimize dialysis parameters to reduce risk of hemodynamic compromise:
Monitoring During and After Hemodialysis
- Monitor vital signs and clinical status throughout the procedure 1
- Assess for resolution of toxicity symptoms (reduced consciousness, confusion, agitation, seizures) 1
- Consider serum drug concentration monitoring when available, though clinical improvement should be the primary endpoint 3, 5
When to Stop Hemodialysis
- Base cessation of hemodialysis on clinical improvement rather than predetermined duration 3
- Key indicators for stopping include:
- Resolution of neurological symptoms
- Hemodynamic stability
- Absence of seizure activity 3
Important Considerations
- Administer medications after hemodialysis sessions to avoid premature removal 3, 5
- For patients on chronic hemodialysis who develop pregabalin toxicity, an additional non-scheduled hemodialysis session should be performed 2
- Consult with nephrology for appropriate dialysis prescription and monitoring 3
- Contact a Certified Poison Control Center for up-to-date management recommendations 1
Potential Complications and Mitigation
- Hemodynamic instability during hemodialysis may occur, particularly in critically ill patients 4
- Strategies to mitigate hemodynamic instability include:
- Cooling the dialysate
- Adjusting dialysate sodium concentration
- Careful monitoring of ultrafiltration rates 4
- Electrolyte disturbances may occur during rapid drug removal; monitor and correct as needed 3